Next-Generation Sequencing Services Market Size Is Estimated To Reach $2.87 Billion By 2025

The global next-generation sequencing (NGS) services market size is expected to reach USD 2.87 billion by 2025 at a 13.6% CAGR during the forecast period, according to a new report by Grand View Research, Inc. The development of NGS technologies has revolutionized gene sequencing in terms of reproducibility and cost savings.

This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end users.

Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For example, in October 2014, ARUP Laboratories collaborated with the Children’s Hospital of Philadelphia (CHOP). The service provision for NGS-based HLA genotyping, including HLA Class II and HLA Class I, began in November 2017.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input.

In July 2017, Norgen released the new Small RNA Library Prep Kit for Illumina. This kit is being developed to generate small RNA libraries and is optimized for samples with low input RNA (0.5-1ng), such as urine, serum, plasma, cerebral spinal fluid (CSF), blood, and exosomes.

Full Research Report On Next-Generation Sequencing Services Market Visit Here: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-services-market

Further key findings from the report suggest:

• Human genome sequencing services held the largest revenue share owing to greater penetration of whole genome and whole exome sequencing
• Gene regulation services, particularly small RNA sequencing and ChIP-seq, is anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is driving the growth of gene regulation services
• An increase in the installation of sequencing platforms is attributive to the larger revenue share of sequencing services as compared to other workflow steps. High maintenance and recovery costs of this step have also resulted in greater revenue generation
• Universities and other research entities have emerged as prominent end users owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
• North America dominated the market by revenue in 2017, owing to higher penetration of the technology in this region and availability of funds to employ the technique and derive research findings for disease targeting
• Various prominent players in this market include Illumina, Inc.; Eurofins Genomics; BGI; and GENEWIZ Germany GmbH. Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers
• Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-services-market/request/rs1

Grand View Research has segmented the global next-generation sequencing services market on the basis of service type, workflow, end use, and region:

NGS Service Type Outlook (Revenue, USD Million, 2014 - 2025)

• Human Genome Sequencing
• Single Cell Sequencing
• Microbial Genome-based Sequencing
• Gene Regulation Services
• Small RNA Sequencing
• ChIP Sequencing
• Other Gene Regulation-based Services
• Animal & Plant Sequencing
• Other Sequencing Services

NGS Services Workflow Outlook (Revenue, USD Million, 2014 - 2025)

• Pre Sequencing
• Sequencing
• Data Analysis

NGS Services End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Universities & Other Research Entities
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

NGS Services Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• The U.S.
• Canada
• Europe
• Germany
• The U.K.
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Middle East & Africa
• South Africa

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com